Hobbs FR, Gbinigie OA, Shanyinde M, Yu LM, et al. Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes. J Infect 2024 Aug 29:106248. doi: 10.1016/j.jinf.2024.106248.
PMID: 39216829